Purdue Pharma Announces First Participant Enrolled in Clinical Study Assessing Nalmefene HCl Injection for the Emergency Treatment of Known or Suspected Opioid Overdose

13

STAMFORD, Conn.–(BUSINESS WIRE)–Purdue Pharma Announces First Participant Enrolled in Clinical Study Assessing Nalmefene HCl Injection for the Emergency Treatment of Known or Suspect….

 

 

 

http://www.businesswire.com/news/home/20190606005766/en/Purdue-Pharma-Announces-Participant-Enrolled-Clinical-Study